Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pulmonx Corp
LUNGCurrent price
4.52 USD
-0.27 USD (-5.64%)
Last closed
6.60 USD
Company
pulmonx.com
ISIN
US7458481014
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
192 785 232 USD
Yield for 12 month
-38.92 %
1Y
3Y
5Y
10Y
15Y
LUNG
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Address: 700 Chesapeake Drive, Redwood City, CA, United States, 94063
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.36 USDP/E ratio
–Dividend Yield
–Current Year
+83 789 000 USD
Last Year
+68 675 000 USD
Current Quarter
+23 765 000 USD
Last Quarter
+20 387 000 USD
Current Year
+62 001 000 USD
Last Year
+50 752 000 USD
Current Quarter
+17 690 000 USD
Last Quarter
+15 026 000 USD
Key Figures LUNG
1 year
3 years
5 years
10 years
EBITDA
-54 494 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-20.55 %
PEG Ratio
–
Return On Equity TTM
-55.26 %
Wall Street Target Price
12.36 USD
Revenue TTM
83 789 000 USD
Book Value
2.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
23.30 %
Dividend Yield
–
Gross Profit TTM
62 001 000 USD
Earnings per share
-1.44 USD
Diluted Eps TTM
-1.44 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-67.31 %
Dividend Analytics LUNG
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History LUNG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation LUNG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
28.33
Enterprise Value Revenue
1.76
Price Sales TTM
2.30
Enterprise Value EBITDA
-5.62
Price Book MRQ
2.25
Financials LUNG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LUNG
For 52 weeks
4.49 USD
10.01 USD
50 Day MA
7.10 USD
Shares Short Prior Month
1 166 359
200 Day MA
6.89 USD
Short Ratio
4.57
Shares Short
1 234 912
Short Percent
4.52 %
BeatStart